Breaking News Instant updates and real-time market news.

RDS.A

Royal Dutch Shell

$51.50

0.95 (1.88%)

, RDS.B

Royal Dutch Shell

$54.82

0.8 (1.48%)

10:22
10/14/16
10/14
10:22
10/14/16
10:22

On The Fly: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Royal Dutch Shell (RDS.A, RDS.B) downgraded to Sell from Hold at Canaccord with the firm citing the gap between the average free cash flow generation of Shell over the past two decades and the medium-term target. 2. bluebird bio (BLUE) downgraded to Sell from Hold at Cantor with analyst Elemer Piros saying he sees a lack of catalysts as he does not expect data to be announced at this year's American Society of Hematology conference to de-risk the hemoglobinopathy programs. 3. Fluor (FLR) downgraded to Neutral from Accumulate at Seaport Global with analyst Ryan Cassil citing persistently weaker global macroeconomic trends and expectations for a continuation of weaker project activity in 2017. 4. Boston Beer (SAM) downgraded to Hold from Buy at Berenberg. 5. Estee Lauder (EL) downgraded to Neutral from Overweight at Piper Jaffray after the firm's semi-annual proprietary "Taking Stock With Teens" survey. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

RDS.A

Royal Dutch Shell

$51.50

0.95 (1.88%)

RDS.B

Royal Dutch Shell

$54.82

0.8 (1.48%)

BLUE

bluebird bio

$65.24

-0.31 (-0.47%)

FLR

Fluor

$49.97

-0.35 (-0.70%)

SAM

Boston Beer

$154.88

-8.3 (-5.09%)

EL

Estee Lauder

$87.80

-0.35 (-0.40%)

  • 03

    Nov

  • 06

    Nov

  • 29

    Nov

RDS.A Royal Dutch Shell
$51.50

0.95 (1.88%)

10/14/16
ADAM
10/14/16
DOWNGRADE
ADAM
Sell
Royal Dutch Shell downgraded to Sell from Hold At Canaccord
Canaccord downgraded Royal Dutch Shell to Sell from Hold based on the gap between the average free cash flow generation of Shell over the past two decades and the medium-term target. Canaccord said the company would require at least a five-fold improvement from the 20-year average and a ten-fold improvement from the 10 year average to make its medium-term goals.
08/10/16
08/10/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Adobe (ADBE) initiated with an Overweight at Stephens. 2. Royal Dutch Shell (RDS.A) coverage resumed with a Market Perform at Raymond James. 3. Sientra (SIEN) resumed with a Market Perform at William Blair. 4. Synchronoss (SNCR) initiated with an Overweight at Stephens. 5. AdvancePierre Foods (APFH) initiated with an Overweight at Morgan Stanley. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/08/16
BERN
09/08/16
DOWNGRADE
BERN
Market Perform
Total downgraded to Market Perform from Outperform at Bernstein
Bernstein analyst Oswald Clint, downgraded Total (TOT) based on his new analysis which shows that its upstream ROIC ranks fifth among the European integrated oil names he covers. The analyst says that Shell (RDS.A), BP (BP), and Eni (E) rank first, second, and third, respectively.He set a $56.61 price target on Total.
09/08/16
BERN
09/08/16
DOWNGRADE
BERN
Underperform
Repsol downgraded to Underperform from Market Perform at Bernstein
Bernstein analyst Oswald Clint downgraded Repsol (REPYY) based on his new analysis which shows that its upstream ROIC ranks sixth among the European integrated oil names he covers. The analyst says that Shell (RDS.A), BP (BP), and Eni (E) rank first, second, and third, respectively. He set an EUR11.30 price target on Repsol, down from EUR13 previously.
RDS.B Royal Dutch Shell
$54.82

0.8 (1.48%)

08/01/16
RBCM
08/01/16
DOWNGRADE
RBCM
Sector Perform
Royal Dutch Shell downgraded on valuation, debt at RBC Capital
As noted earlier, RBC Capital downgraded Royal Dutch Shell to Sector Perform from Outperform. As reasons for the downgrade, analyst Biraj Borkhataria cited valuation and the company's debt burden.
03/11/16
03/11/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Finisar (FNSR) upgraded to Buy at Craig-Hallum and B. Riley, following the company's Q3 results. Craig-Hallum analyst Richard Shannon was encouraged by guidance in a seasonally difficult part of Finisar's year and believes the company has reached the inflection point he has been waiting for. 2. Diamond Offshore (DO) upgraded to Neutral at Goldman and Piper Jaffray, with analysts citing an improved relative valuation, the company's balance sheet, and liquidity. 3. Cenovus Energy (CVE) upgraded to Conviction Buy at Goldman by analyst Neil Mehta, who cited the company's strong 2017 free cash flows, improving commodity prices, high quality assets, and relative underperformance. 4. Weatherford (WFT) upgraded to Buy at Goldman with analyst Waqar Syed saying Weatherford will be a beneficiary of an expected recovery in US land drilling activity in 2017. He added that investors will benefit from cost cutting and restructuring measures taken over the past two years. 5. Royal Dutch Shell (RDS.A) upgraded to Conviction Buy at Goldman due to expectations for a growing dividend yield driven by cost cutting, capital discipline, the realization of synergies, and rising oil prices. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
BLUE bluebird bio
$65.24

-0.31 (-0.47%)

10/14/16
LEER
10/14/16
NO CHANGE
Target $80
LEER
Outperform
bluebird bio price target raised to $80 from $67 at Leerink
Leerink analyst Michael Schmidt raised his price target for bluebird bio to $80 from $67 as he sees the clinical development and regulatory path for the company's pipeline products incrementally more de-risked. While development of key product LentiGlobin in transfusion-dependent beta-thalassemia and severe sickle cell disease has been more complex than initially anticipated, the analyst believes bluebird bio is well positioned to overcome remaining technical hurdles. He reiterates an Outperform rating on the shares.
10/14/16
CANT
10/14/16
DOWNGRADE
Target $37
CANT
Sell
Cantor cuts bluebird bio to Sell with $37 price target
Cantor Fitzgerald analyst Elemer Piros downgraded bluebird bio to Sell from Hold and dropped his price target for the shares to $37 from $42. The biotech focused on developing gene therapies closed yesterday down 31c to $64.24. The analyst sees a lack of catalysts as he does not expect data to be announced at this year's American Society of Hematology conference to de-risk the hemoglobinopathy programs. Bluebird disclosed yesterday that all future LentiGlobin trials going forward will use its improved manufacturing process, and those trials are just beginning, Piros tells investors in a research note. As such, initial data on improved transduction efficiency may not become available until 2018, the analyst contends. With this year's ASH meeting not a catalyst, Piros expects selling pressure on bluebird shares.
10/14/16
CANT
10/14/16
DOWNGRADE
CANT
Sell
bluebird bio downgraded to Sell from Hold at Cantor
Cantor Fitzgerald analyst Elemer Piros downgraded bluebird bio to Sell and cut his price target for the shares to $37 from $42.
10/14/16
RHCO
10/14/16
NO CHANGE
RHCO
bluebird bio outlook has improved, says SunTrust
SunTrust analyst Edward Nash believes that the improvement in the transduction efficiency of bluebird's LentiGlobin should enable the company "to target the entire transfusion-dependent B-thalassemia population" for the first time. Nash adds that the changes should also improve LentiGlobin's efficacy in sickle cell. He reiterates a $115 price target and Buy rating on the stock.
FLR Fluor
$49.97

-0.35 (-0.70%)

05/06/16
ADAM
05/06/16
DOWNGRADE
ADAM
Hold
Fluor downgraded to Hold from Buy at Canaccord
06/28/16
MKMP
06/28/16
INITIATION
MKMP
Neutral
Fluor initiated with a Neutral at MKM Partners
07/05/16
FBCO
07/05/16
NO CHANGE
FBCO
Outperform
Fluor scope on 'imminent' project could be multiple billions, says Credit Suisse
Credit Suisse Jamie Cook noted that the Tengizchevron joint venture, which is 50% owned by Chevron (CVX), 25% by ExxonMobil (XOM), 20% owned by KazMunayGas, and 5% owned by Lukoil, has announced plans to move forward with the TCO project, adding that Fluor (FLR) has been doing extensive work on TCO with its JV partner WorleyParsons and that most investors believed the likelihood of this project moving forward was "minimal." Cook, who believes Fluor's scope on this project could be "north of a couple billion" and that the company could book this award in Q2 or Q3 of this year, has an Outperform rating on Fluor shares.
10/14/16
GHSC
10/14/16
DOWNGRADE
Target $50
GHSC
Neutral
Fluor downgraded to Neutral from Accumulate at Seaport Global
Seaport Global analyst Ryan Cassil downgraded Fluor to Neutral and lowered its price target to $50 from $53 to account for persistently weaker global macroeconomic trends and expectations for a continuation of weaker project activity in 2017.
SAM Boston Beer
$154.88

-8.3 (-5.09%)

09/21/16
COWN
09/21/16
DOWNGRADE
Target $128
COWN
Underperform
Boston Beer downgraded to Underperform at Cowen
As reported previously, Cowen analyst Vivien Azer downgraded Boston Beer to Underperform from Market Perform. The analyst cited its string of disappointing monthly Nielsen data and structural headwinds to the company's core assets, which present meaningful earnings risk. Azer lowered her price target to $128 from $170 on Boston Beer shares, which were also initiated with an Outperform rating by William Blair analyst Jon Andersen this morning.
10/14/16
BREN
10/14/16
DOWNGRADE
BREN
Hold
Boston Beer downgraded to Hold from Buy at Berenberg
09/21/16
09/21/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Starbucks (SBUX) initiated with a Buy at Longbow. 2. Boston Beer (SAM) initiated with an Outperform at William Blair. 3. Altria Group (MO) was initiated with a Hold at Jefferies while the firm initiated Reynolds American (RAI) with a Buy. 4. Dick's Sporting (DKS) initiated with a Neutral at Guggenheim. 5. E-Trade (ETFC) reinstated with an Outperform at Credit Suisse. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/21/16
09/21/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Wells Fargo (WFC) downgraded to Neutral from Overweight at JPMorgan with analyst Vivek Juneja saying the "tough" Senate hearings and "mounting public scrutiny" will likely result in additional investigations that could pressure expenses. 2. Skechers (SKX) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Jay Sole saying he believes consumers shift towards pure fashion styles and away from athletic footwear is causing Skechers to adjust assortment, resulting in slower sales growth. 3. American Airlines (AAL) downgraded to Market Perform from Outperform at Raymond James analyst Savanthi Syth citing relative valuation and lowered estimates to reflect the new mechanics contract. 4. Boston Beer (SAM) downgraded to Underperform from Market Perform at Cowen with analyst Vivien Azer citing its string of disappointing monthly Nielsen data and structural headwinds to the company's core assets, which present meaningful earnings risk. 5. Children's Place (PLCE) downgraded to Neutral from Overweight at Piper Jaffray with analyst Stephanie Wissink saying the firm's recent survey of moms pointed to a "step down" in mindshare. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
EL Estee Lauder
$87.80

-0.35 (-0.40%)

10/13/16
PIPR
10/13/16
DOWNGRADE
PIPR
Neutral
Estee Lauder downgraded to Neutral from Overweight at Piper Jaffray
10/13/16
PIPR
10/13/16
DOWNGRADE
PIPR
Neutral
Estee Lauder downgraded to Neutral after teen survey at Piper Jaffray
As previously reported, Piper Jaffray analyst Steph Wissink downgraded Estee Lauder to Neutral from Overweight following the firm's semi-annual proprietary "Taking Stock With Teens" survey. The company's brands have ceded share both year-over-year and sequentially since spring, noted Wissink, who added that she believes its legacy brands are less able to rely on traditional marketing and promotion to gain share. The analyst cut her price target on Estee Lauder to $90 from $98.
10/13/16
PIPR
10/13/16
UPGRADE
Target $44
PIPR
Overweight
Under Armour upgraded to Overweight after teen survey at Piper Jaffray
As previously reported, Piper Jaffray analyst Erinn Murphy upgraded Under Armour (UA) to Overweight from Neutral following the firm's semi-annual proprietary "Taking Stock With Teens" survey. The survey findings support on-going traction for Under Armour within footwear and the women's segment, noted Murphy, who raised her price target on the stock to $44 from $40. Based on the survey's results, other analysts at the firm also downgraded Estee Lauder (EL) to Neutral from Overweight and upgraded Zumiez (ZUMZ) to Overweight from Neutral.
10/03/16
PIPR
10/03/16
NO CHANGE
PIPR
Chinese tax changes modestly positive for cosmetics makers, says Piper Jaffray
Piper Jaffray analyst Stephanie Wissink noted that the Chinese Ministry of Finance has reduced or eliminated the consumption tax on all cosmetic products as of October 1 to stimulate demand and growth, which she views as a modest positive for Estee Lauder (EL), Avon Products (AVP) and Coty (COTY). Of the three, Estee Lauder has the highest exposure to China, which makes up about 10% of its annual revenues, Wissink added.

TODAY'S FREE FLY STORIES

CNX

CONSOL

$21.30

-0.48 (-2.20%)

, CNNX

CONE Midstream

$21.33

-0.15 (-0.70%)

15:02
12/10/16
12/10
15:02
12/10/16
15:02
Conference/Events
CONE Midstream participates in an analyst and investor day »

Management participates…

CNX

CONSOL

$21.30

-0.48 (-2.20%)

CNNX

CONE Midstream

$21.33

-0.15 (-0.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

CNNX

CONE Midstream

$21.33

-0.15 (-0.70%)

, CNX

CONSOL

$21.30

-0.48 (-2.20%)

14:59
12/10/16
12/10
14:59
12/10/16
14:59
Conference/Events
CONSOL to host analyst and investor day »

Analyst and Investor Day…

CNNX

CONE Midstream

$21.33

-0.15 (-0.70%)

CNX

CONSOL

$21.30

-0.48 (-2.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

BG

Bunge

$73.36

-0.04 (-0.05%)

14:54
12/10/16
12/10
14:54
12/10/16
14:54
Conference/Events
Bunge to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMD

AMD

14:50
12/10/16
12/10
14:50
12/10/16
14:50
Conference/Events
AMD to host Summit Ridge a "Zen"-based CPU at New Horizon »

President & CEO Su…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AJG

Arthur J. Gallagher

$50.76

0.61 (1.22%)

14:41
12/10/16
12/10
14:41
12/10/16
14:41
Conference/Events
Arthur J. Gallagher to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

NYT

New York Times

$14.10

0.15 (1.08%)

14:34
12/10/16
12/10
14:34
12/10/16
14:34
Conference/Events
Detroit Economic Club to hold a luncheon meeting »

Mark Thompson, President…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZN

AstraZeneca

$27.16

0.89 (3.39%)

14:28
12/10/16
12/10
14:28
12/10/16
14:28
Conference/Events
AstraZeneca has a luncheon meeting with Philadelphia Securities Association »

Luncheon Meeting being…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 16

    Feb

CASC

Cascadian Therapeutics

$5.65

-0.03 (-0.53%)

, GHDX

Genomic Health

$30.81

-0.17 (-0.55%)

04:55
12/10/16
12/10
04:55
12/10/16
04:55
Conference/Events
UT Health Science Center to hold a symposium »

2016 San Antonio Breast…

CASC

Cascadian Therapeutics

$5.65

-0.03 (-0.53%)

GHDX

Genomic Health

$30.81

-0.17 (-0.55%)

MYGN

Myriad Genetics

$17.40

0.41 (2.41%)

RDUS

Radius Health

$43.94

-3.13 (-6.65%)

OCX

OncoCyte

$6.15

0.05 (0.82%)

ABBV

AbbVie

$61.54

0.64 (1.05%)

BAYRY

Bayer

$100.04

1.14 (1.15%)

CELG

Celgene

$113.47

0.41 (0.36%)

CLDX

Celldex

$3.75

0.01 (0.27%)

DNA

Bought by RHHBY

HRTX

Heron Therapeutics

$14.90

-0.55 (-3.56%)

PFE

Pfizer

$31.70

0.76 (2.46%)

PBYI

Puma Biotechnology

$36.50

0.05 (0.14%)

TSRO

TESARO

$129.97

-1.57 (-1.19%)

NSTG

NanoString

$21.79

-0.35 (-1.58%)

NVS

Novartis

$69.74

2.15 (3.18%)

NVTA

Invitae

$7.24

0.28 (4.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 11

    Jan

BBSI

Barrett Business

$62.30

1.85 (3.06%)

, BREW

Craft Brew

$16.65

0.45 (2.78%)

04:55
12/10/16
12/10
04:55
12/10/16
04:55
Conference/Events
Roth Capital to hold a conference »

5th Annual ROTH Utah…

BBSI

Barrett Business

$62.30

1.85 (3.06%)

BREW

Craft Brew

$16.65

0.45 (2.78%)

CHKE

Cherokee

$11.10

-0.35 (-3.06%)

DFBG

Differential Brands

$3.20

0.25 (8.47%)

DLA

Delta Apparel

$20.77

-0.39 (-1.84%)

ESCA

Escalade

$13.65

-0.15 (-1.09%)

FLKS

Flex Pharma

$6.29

-0.01 (-0.16%)

KONA

Kona Grill

$12.75

0.05 (0.39%)

LNDC

Landec

$15.05

-0.25 (-1.63%)

MEET

MeetMe

$5.63

0.16 (2.93%)

MITK

Mitek Systems

$6.50

0.35 (5.69%)

MB

MINDBODY

$20.70

-0.25 (-1.19%)

OSIS

OSI Systems

$78.17

1.22 (1.59%)

PLNT

Planet Fitness

$21.01

-0.07 (-0.33%)

ROX

Castle Brands

$0.75

0.0309 (4.30%)

PRTS

U.S. Auto Parts

$3.33

0.09 (2.78%)

RSYS

RadiSys

$4.77

0.11 (2.36%)

SWHC

Smith & Wesson

$21.07

-0.16 (-0.75%)

VSTO

Vista Outdoor

$38.62

-1.24 (-3.11%)

WMAR

West Marine

$9.41

0.13 (1.40%)

ZAGG

ZAGG

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 12

    Dec

  • 13

    Dec

  • 13

    Dec

  • 09

    Jan

ANET

Arista Networks

$94.41

-1.35 (-1.41%)

, CSCO

Cisco

$30.06

0.11 (0.37%)

18:32
12/09/16
12/09
18:32
12/09/16
18:32
Hot Stocks
Arista Networks favored in ITC initial determination on four of six patents »

Arista Networks (ANET)…

ANET

Arista Networks

$94.41

-1.35 (-1.41%)

CSCO

Cisco

$30.06

0.11 (0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 12

    Dec

  • 12

    Dec

TKTDY

Takata Corporation

$10.70

0.05 (0.47%)

18:22
12/09/16
12/09
18:22
12/09/16
18:22
Periodicals
U.S. DOT looks to accelerate pace of Takata air bag replacements, Reuters says »

The U.S. Department of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DV

DeVry

$31.90

0.9 (2.90%)

18:17
12/09/16
12/09
18:17
12/09/16
18:17
Hot Stocks
Breaking Hot Stocks news story on DeVry »

International Value…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

CSOD

Cornerstone OnDemand

$39.10

-0.11 (-0.28%)

18:10
12/09/16
12/09
18:10
12/09/16
18:10
Periodicals
Cornerstone OnDemand considers sale amid activist pressure, Bloomberg reports »

Cornerstone OnDemand has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVM

CEL-SCI

$0.12

-0.0014 (-1.17%)

18:03
12/09/16
12/09
18:03
12/09/16
18:03
Hot Stocks
NYSE MKT says CEL-SCI noncompliant with certain listing requirements »

CEL-SCI reported on a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOM

Exxon Mobil

$89.00

0.68 (0.77%)

18:01
12/09/16
12/09
18:01
12/09/16
18:01
Periodicals
Exxon CEO Tillerson emerges as top candidate for secretary of state, WSJ says »

Exxon Mobil CEO Rex…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FUL

H.B. Fuller

$50.36

0.05 (0.10%)

17:58
12/09/16
12/09
17:58
12/09/16
17:58
Hot Stocks
H.B. Fuller announces restructuring, to eliminate, relocate 220 positions »

H.B. Fuller has announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIIB

Biogen

$287.77

-1.77 (-0.61%)

17:53
12/09/16
12/09
17:53
12/09/16
17:53
Periodicals
Biogen looks like a bargain, Barron's reports »

Biogen trades at just…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNY

Sanofi

$40.40

0.63 (1.58%)

17:42
12/09/16
12/09
17:42
12/09/16
17:42
Periodicals
Sanofi to lay off 20% of U.S. diabetes, cardiovascular staff, Bloomberg says »

The layoffs include parts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Mar

CSOD

Cornerstone OnDemand

$39.10

-0.11 (-0.28%)

17:38
12/09/16
12/09
17:38
12/09/16
17:38
Periodicals
Cornerstone OnDemand considers sale amid activist pressure, Bloomberg reports »

Investor Praesidium said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TACO

Del Taco

$14.75

-0.39 (-2.58%)

17:34
12/09/16
12/09
17:34
12/09/16
17:34
Hot Stocks
Breaking Hot Stocks news story on Del Taco »

PW Acquisitions cuts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jan

  • 09

    Jan

  • 09

    Dec

UNVR

Univar

$26.36

0.54 (2.09%)

, BXLT

Baxalta

17:30
12/09/16
12/09
17:30
12/09/16
17:30
Hot Stocks
Univar names Eric Foster chief information officer »

Univar (UNVR) named Eric…

UNVR

Univar

$26.36

0.54 (2.09%)

BXLT

Baxalta

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PARN

Parnell

$1.42

-0.0031 (-0.22%)

17:30
12/09/16
12/09
17:30
12/09/16
17:30
Hot Stocks
Breaking Hot Stocks news story on Parnell 

Parnell trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BSX

Boston Scientific

$20.81

0.2 (0.97%)

, NVRO

Nevro

$76.38

-1.88 (-2.40%)

17:24
12/09/16
12/09
17:24
12/09/16
17:24
Hot Stocks
Boston Scientific files patent infringement suit against Nevro »

Nevro (NVRO) announced…

BSX

Boston Scientific

$20.81

0.2 (0.97%)

NVRO

Nevro

$76.38

-1.88 (-2.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

RTN

Raytheon

$146.30

0.14 (0.10%)

17:21
12/09/16
12/09
17:21
12/09/16
17:21
Hot Stocks
Raytheon awarded $101.9M government contract »

Raytheon Co., Goleta,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CX

CEMEX

$8.77

-0.16 (-1.79%)

17:18
12/09/16
12/09
17:18
12/09/16
17:18
Hot Stocks
CEMEX receives subpoena from SEC regarding Foreign Corrupt Practices Act »

On December 9, 2016,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.